No Prescription |
 |
 | ||
|
Lantus Solostar Lantus OptiClik Cartridge |
|
| ||
No Prescription » Prescription Drugs 9 » Lantus Solostar Lantus OptiClik Cartridge Medical Information:Insulin Glargine is used for: Treating diabetes mellitus. Insulin glargine is a man-made form of a hormone that is produced in the body. It works by lowering levels of glucose (sugar) in the blood. Insulin glargine is a long-acting form of insulin that is slightly different from other forms of insulin that are not man-made.Insulin glargine is used to treat type 1 (insulin-dependent) or type 2 (non insulin-dependent) diabetes.Insulin glargine(IN-su-lin GLARE-jeen) is a type of insulin. Insulin is one of many hormones that help the body turn the food we eat into energy. This is done by using the glucose (sugar) in the blood as quick energy. Also insulin helps us store energy that we can use later. When you have type 2 diabetes mellitus your body does not produce enough insulin or the insulin produced is not used properly. This causes you to have too much sugar in your blood. Like other types of insulin insulin glargine is used to keep your blood sugar level close to normal. Insulin glargine is a long-acting insulin that works slowly over about 24 hours. You may have to use insulin glargine in combination with another type of insulin or with a type of oral diabetes medicine to keep your blood sugar under control. Buy Lantus Solostar Lantus OptiClik Cartridge and other Prescription Drugs 9 products online at Medstore. 3681
About Lantus Solostar Lantus OptiClik Cartridge: Product Type: Prescription Drugs 9 Lantus Solostar ( Lantus OptiClik Cartridge Lantus Optipen Generic Insulin Glargine ) Lantus Solostar (Lantus OptiClik Cartridge Lantus Optipen Generic Insulin Glargine) Lantus OptiClik Cartridge Lantus Optipen Generic Insulin Glargine 100U/ml 5 x 3ml Lantus OptiClik Cartridge Lantus Optipen Generic Insulin Glargine Lantus Solostar
View more Prescription Drugs 9 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
